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The representativeness of a cellular model 
is fundamental in preclinical cancer studies, 
being defined as the degree of likelihood 
between the in vitro model and the in vivo 
mimicked tumor situation. Although being 
the gold standard in cell biology for more 
than a half century, 2D cell cultures poorly 
represent the complex three-dimension-
ality of in vivo conditions. Size, heteroge-
neity and perfusion are three key aspects 
characterizing the behavior of the tumor 
and driving its progression. In this regard, it 
has been widely proven that 3D multicellular 
models enable a more reliable assessment 
of anti-cancer drugs and radiotherapy treat-
ments, although a recent article emphasized 
that today there are no well-established 
approaches to obtain relevant biological 
data from these models [1]. Moreover, there 
are not even shared definitions of multicel-
lular aggregates, spheroids, microtissues 
and organoids. Therefore, this work provides 
an opening rationale for the different terms 
today used for 3D cell cultures and discusses 
the benefits of using large-sized spheroids 
as 3D preclinical culture models. Finally, 
this work outlines the microfluidic systems 
that are now ready for 3D culture cultivation 
and manipulation in dynamic controlled 
conditions, this representing a further step 
towards more representative 3D in vitro 
cancer models.
Based on the structural and conse-
quently functional complexity, multicel-
lular aggregates can be considered as the 
simplest 3D cell cultures, as they are charac-
terized by a 3D cell–cell aggregation free 
from a defined structural obligation. The 
commonly used term spheroids should be 
referred to those multicellular aggregates 
producing their own extracellular matrix and 
having a nearly spherical shape [2]. When 
spheroids comprise more than one cell 
types that together accomplish a specific 
function, referring to them as microtissues 
is more appropriate. However, the use of 
the terms spheroids and microtissues is 
still often overlapping. It is worth noting 
that if the spheroids are composed of more 
than one cell type not accomplishing a 
specific function together, they can be better 
identified as co-culture spheroids. Finally, 
self-renewing multicellular aggregates that 
self-organize into ex vivo mini-organs are 
named organoids [3].
Whilst complex cell culture models 
enable representation of many in vivo 
parameters and interactions, spheroids are 
a simple yet effective model to represent 
in vivo tumor conditions while retaining 
handiness in their generation and use. 
Furthermore, it is known that when their 
diameter exceeds the threshold of approx-
imately 500 μm, spheroids become more 
heterogeneous, since they develop a 
necrotic core surrounded by a viable rim of 
quiescent cells and an outer layer of prolif-
erating cells. This structure mimics the one 
of vascular tumor nodules and microregions 
of solid tumors, where cells next to capil-
laries are actively proliferating and distant 
inner cells stay quiescent or die due to mass 
transport limitations. Accordingly, stratified 
large-sized spheroids are a more represen-
tative model of in vivo intra-tumor heteroge-
neity, an aspect widely reported to impact on 
many cancer-specific traits such as clono-
genicity, invasive potential and response to 
drugs [2].
A further improvement in the representa-
tiveness of a cellular model can be achieved 
by taking into account the tumor microen-
vironment, which has been extensively 
proven to play a key role in several steps of 
tumor progression, from initial neoplastic 
transformation to an eventual metastatic 
invasion. Traditional culture methods are 
static and thus often limiting for reshaping 
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dynamic in vivo conditions, where cells 
may undergo phenomena such as inter-
stitial flow-derived mechanical stresses and 
spatial and temporal variation in chemical 
and physical factors. In this regard, micro-
fluidic systems can be used as tools to 
actively mimic and modulate parameters 
of the culture environment [4].
Microfluidic systems are those 
platforms and technologies that allow 
manipulaton of tiny amounts of fluids using 
microstructures from tens to hundreds 
of micrometers. Microfluidic devices 
can be coupled to 3D cellular models 
to: (a) provide continuous perfusion of 
fresh culture medium, which replenishes 
cells with nutrients while removing toxic 
wastes; (b) perform a fine manipulation of 
biophysical and biochemical parameters, 
such as chemical gradients, metabolic 
stress and fluid flows; (c) allow real-time 
imaging and monitoring of the culture in 
dynamics, also through the integration of 
different biosensors on-board [5].
Many of the developed microfluidic 
devices permit high-throughput culti-
vation and parallel analysis of 3D cell 
cultures. Nonetheless, there are still limits 
to their widespread use as general purpose 
systems. Precisely: (a) most devices are 
conceived just for microscale cultures 
and do not support 3D aggregates above 
hundreds of micrometers in size; (b) not all 
the existing microfluidic systems permit the 
individual interrogation of aggregates on the 
same device, nor their harvesting for later 
analysis [2]; (c) to support and protect the 
culture integrity, microfluidic devices often 
require the use of artificial scaffolds, which 
may have non-physiological compositions, 
leading to cellular aberrations [2]; (d) many 
microfluidic devices are of specific purpose, 
having complex peculiar capillary structure 
that results in a high tissue specificity, but 
also reduced applicability of the system out 
of its native context [6]. These drawbacks 
make common microfluidic systems 
unsuitable to culture in vitro 3D multicel-
lular spheroids of relevant size (e.g., above 
500 μm). In particular, only three technol-
ogies bypass these four drawbacks and are 
available at the present time: (a) the organ-
on-chip device, developed by Schimek et al. 
(TissUse GmbH, Berlin, Germany) [7]; (b) the 
microfluidic hanging-drop network (HDN) 
by Misun et al. (InSphero AG, Schlieren, 
Switzerland) [8]; (c) the multicompart-
mental modular bioreactor (MCmB) by 
Mazzei et al. (commercialized by Kirkstall 
Ltd, Rotherdam, UK and recently by IVTech 
Srl, Massarosa, Italy) [9]. A schematic of 
the culture unit of each of these technol-
ogies is reported in Supplementary Figure 
S1, whilst a comparative overview can be 
found in Supplementary Table S1.
The organ-on-chip device is a chip-sized 
system originally intended to investigate 
flow-driven shear stress effects on human 
endothelial cells. The system is endowed 
with an on-board micropump supporting 
steady long-term fluid flow through a micro-
channel system fully covered by cells [7]. 
Although initially developed as a tissue-
specific platform, the system has been 
revised and is actually commercialized 
in the form of 2-organ-chip and 4-organ-
chip by TissUse GmbH. These systems 
respectively comprise two and four culture 
chamber units, thus enabling simultaneous 
cultivation of up to two and four different 
multicellular aggregates in a common 
media perfusion circuit at a miniaturized 
scale. The systems are also compatible 
with standard Transwell inserts and with 
matrix supports, thus allowing modelling 
biological barriers and the reproduction of 
parenchymal organs environment.
The HDN extends traditional hanging-
drop technology by creating a reconfigu-
rable microfluidic network. The device 
is based on a micropatterned surface 
of channels and circular areas for drop 
formation, resulting in a network of drops 
connected by a common flowing medium 
driven by an external pump. The medium 
perfusion permits substance dosage and 
nutrient supply, thus extending the in-culture 
maintenance of the spheroids. Moreover, 
capillary valves within the network enable 
the reconfiguration of drop interconnections 
and consequent different multi-aggregates 
experimental settings [8]. The system has 
recently been commercialized by InSphero 
AG under the name of 3D InSight™ Micro-
tissues, namely an assay-ready system 
consisting of HCN-derived Akura™ plates, in 
96- or 384-well format, which already incor-
porates preformed microtissues in different 
formats (InSphero AG).
MCmB is a modular fluidic system 
powered by an external peristaltic pump and 
equipped with a mixing chamber primarily 
acting as a gas exchanger and flow rectifier. 
The culture chamber’s roof is specifically 
designed to minimize shear stress on the 
cells while applying relatively high flow 
rates that maximize oxygen delivery to the 
culture. Having the size of a 24-plate well, 
the chambers support routine laboratory 
protocols and procedures, including 
standard Transwell utilization to mimic 
epithelial structures. The MCmB is today 
available in several configurations (Supple-
mentary Figure S2): (a) the QV500 Quasi 
Vivo chamber (Kirkstall Ltd), characterized 
by single inlet and outlet and a sloping 
roof; (b) the LiveBox1 (IVTech Srl), charac-
terized by single inlet and outlet and a flat 
optically transparent roof for optimizing live 
optical imaging during the experiments; (c) 
the LiveBox2 (IVTech Srl), characterized by 
two inlets and two outlets, a flat optically 
transparent roof, and a membrane holder for 
physiological barrier simulation. In spite of 
their differences, all these system designs 
are based on allometric scaling principles, 
thus allowing for interconnection of different 
2D/3D culture types in a metabolically and 
physiologically relevant manner [10].
In conclusion, this work presents the 
perfusion systems that are actually able to 
perform in vitro cultivation and manipulation 
of multicellular spheroids of relevant size 
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how the adoption of such microfl uidic 
systems for culture and interrogation of 
heterogeneous large-sized spheroids 
maximizes the  in vitro resemblance of the 
 in vivo complexity. Generation technologies 
and imaging systems are today ready to 
deal with large-size spheroids  [1] . Herewith, 
if on one hand some advancements lack 
for extracting quantitative data at single-
cell level and performing deep high-content 
screening analyses, on the other hand 
the use of fl uidic systems together with 
spheroids larger than 500 μm actually repre-
sents the best trade-off between handiness 
of a model’s parameters and possibility to 
obtain reliable and reproducible biological 
data in preclinical studies. 
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